Back to search

Article

A rationally designed peptidomimetic modulator of CaV2.2 (N-type) voltage-gated calcium channels for chronic pain

2022-09-12

Abstract excerpt

<h4>Background: </h4> and Purpose Transmembrane Cav2.2 (N-type) voltage-gated calcium channels are genetically and pharmacologically validated pain targets. Clinical block of Cav2.2 (e.g., with Prialt) or indirect modulation (e.g., with gabapentinoids) mitigates chronic pain but is constrained by side effects. The cytosolic auxiliary subunit collapsin response mediator protein 2 (CRMP2) targets Cav2.2 to the senso...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f745b9fa-f758-5416-84e5-2e3a5081bb08
DOI
10.22541/au.166299307.78275508/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A rationally designed peptidomimetic modulator of CaV2.2 (N-type) voltage-gated calcium channels for chronic painDOI 10.22541/au.166299307.78275508/v1
Select a neighboring publication to make it the new centre.